21. ctDx NSCLC assay: From diagnostic laboratory to patient care, development, validation, and clinical utility, case review
Lung cancer is the second most common cancer in both men and women. The American Cancer Society's estimates about 228,820 new cases of lung cancer and about 135,720 deaths from lung cancer in 2020. The clinical outcome of the lung cancer patients has markedly improved since the advent of molecular diagnostic tests having the evidence of clinical utility.
Source: Cancer Genetics and Cytogenetics - Category: Genetics & Stem Cells Authors: Seyed Ali Hosseini Source Type: research
More News: Cancer | Cancer & Oncology | Genetics | Laboratory Medicine | Lung Cancer | Non-Small Cell Lung Cancer | Women